ProfileGDS4132 / 212318_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 85% 85% 84% 82% 83% 85% 82% 79% 86% 84% 80% 88% 86% 86% 80% 79% 82% 87% 86% 84% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101319.44185
GSM201543Muscle PCOS pioglitazone 121305.16785
GSM201544Muscle PCOS pioglitazone 161333.41484
GSM201545Muscle PCOS pioglitazone 201314.76582
GSM201829Muscle PCOS pioglitazone 231311.78383
GSM201830Muscle PCOS pioglitazon 251330.68485
GSM201831Muscle PCOS pioglitazone 271301.21482
GSM201832Muscle PCOS pioglitazone 31254.61279
GSM201833Muscle PCOS pioglitazone 41344.04386
GSM201834Muscle PCOS pioglitazone 81329.86784
GSM201835Muscle PCOS after pioglitazone 102280.77980
GSM201836Muscle PCOS after pioglitazone 122385.11188
GSM201837Muscle PCOS after pioglitazone 162336.88586
GSM201838Muscle PCOS after pioglitazone 202373.09286
GSM201839Muscle PCOS after pioglitazone 232290.78480
GSM201840Muscle PCOS after pioglitazone 252285.77979
GSM201841Muscle PCOS after pioglitazone 272283.61682
GSM201842Muscle PCOS after pioglitazone 32362.27787
GSM201843Muscle PCOS after pioglitazone 42361.08286
GSM201844Muscle PCOS after pioglitazone 82340.97484